Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['legend bio', 'legendbio']
as #asco23 comes to a close and we look forward to #eha23, our ceo ying huang, ph.d., shares what he found most exciting from this year s presentations. learn more about the key data here: 
We are a global #celltherapy company focused on developing, manufacturing and commercializing #cancer treatments. $LEGN